| Primary |
| Type 2 Diabetes Mellitus |
58.7% |
| Product Used For Unknown Indication |
12.4% |
| Diabetes Mellitus |
7.4% |
| Diabetes |
2.5% |
| Hepatic Steatosis |
2.5% |
| Cardiovascular Event Prophylaxis |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Hypertension |
1.7% |
| Insulin Resistance |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Analgesic Therapy |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Blood Insulin Abnormal |
0.8% |
| Blood Iron Decreased |
0.8% |
| Cerebrovascular Accident Prophylaxis |
0.8% |
| Constipation |
0.8% |
| Decreased Appetite |
0.8% |
| Diabetes Mellitus Non-insulin-dependent |
0.8% |
| Drug Therapy |
0.8% |
| Epilepsy |
0.8% |
|
| Bladder Cancer |
13.6% |
| Bladder Transitional Cell Carcinoma |
13.6% |
| Hepatocellular Injury |
9.1% |
| Maternal Exposure During Pregnancy |
6.8% |
| Renal Failure Acute |
6.8% |
| Cerebrovascular Accident |
4.5% |
| Normochromic Normocytic Anaemia |
4.5% |
| Osteonecrosis |
4.5% |
| Paraesthesia |
4.5% |
| Prostate Cancer |
4.5% |
| Pterygium |
4.5% |
| Tricuspid Valve Incompetence |
4.5% |
| Acute Left Ventricular Failure |
2.3% |
| Bladder Neoplasm |
2.3% |
| Bladder Transitional Cell Carcinoma Stage I |
2.3% |
| Blood Glucose Increased |
2.3% |
| Blood Sodium Decreased |
2.3% |
| Bone Marrow Oedema |
2.3% |
| Confusional State |
2.3% |
| Coronary Artery Disease |
2.3% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
26.1% |
| Product Used For Unknown Indication |
18.5% |
| Diabetes Mellitus |
15.7% |
| Hypertension |
9.4% |
| Drug Use For Unknown Indication |
4.9% |
| Iron Deficiency |
2.4% |
| Cardiovascular Event Prophylaxis |
2.1% |
| Completed Suicide |
2.1% |
| Congestive Cardiomyopathy |
2.1% |
| Constipation |
2.1% |
| Hypercholesterolaemia |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Blood Calcium |
1.4% |
| Blood Cholesterol |
1.4% |
| Dyslipidaemia |
1.4% |
| Emphysema |
1.4% |
| Metastatic Malignant Melanoma |
1.4% |
| Nausea |
1.4% |
| Renal Cancer |
1.4% |
| Ulcer |
1.4% |
|
| Renal Failure |
18.6% |
| Myalgia |
9.3% |
| Completed Suicide |
7.0% |
| Respiratory Tract Infection |
7.0% |
| Toxicity To Various Agents |
7.0% |
| Abdominal Pain |
4.7% |
| Bladder Cancer |
4.7% |
| Confusional State |
4.7% |
| Interstitial Lung Disease |
4.7% |
| Overdose |
4.7% |
| Sciatica |
4.7% |
| Vomiting |
4.7% |
| Blood Glucose Increased |
2.3% |
| Coronary Artery Stenosis |
2.3% |
| Dehydration |
2.3% |
| Diabetes Mellitus Inadequate Control |
2.3% |
| Drug Toxicity |
2.3% |
| Dyspnoea |
2.3% |
| Fatigue |
2.3% |
| Femur Fracture |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
17.1% |
| Type 2 Diabetes Mellitus |
16.3% |
| Diabetes Mellitus |
14.8% |
| Product Used For Unknown Indication |
13.9% |
| Hypertension |
9.4% |
| Hyperlipidaemia |
4.1% |
| Hiv Infection |
3.9% |
| Rheumatoid Arthritis |
3.8% |
| Prophylaxis |
2.8% |
| Hypercholesterolaemia |
2.4% |
| Pain |
2.3% |
| Angina Pectoris |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Infection Prophylaxis |
1.1% |
| Constipation |
1.0% |
| Insomnia |
1.0% |
| Idiopathic Pulmonary Fibrosis |
0.9% |
| Coronary Artery Disease |
0.8% |
| Pharyngeal Cancer |
0.8% |
| Acute Myeloid Leukaemia |
0.7% |
|
| Vomiting |
9.0% |
| Neutropenia |
7.4% |
| Wrong Technique In Drug Usage Process |
7.4% |
| Rhabdomyolysis |
6.6% |
| Weight Decreased |
6.6% |
| White Blood Cell Count Decreased |
5.7% |
| Breast Cancer |
4.9% |
| Hypoglycaemia |
4.9% |
| Liver Disorder |
4.9% |
| Androgenetic Alopecia |
4.1% |
| Hepatic Function Abnormal |
4.1% |
| Pancreatic Carcinoma |
4.1% |
| Pancreatitis Acute |
4.1% |
| Renal Failure Acute |
4.1% |
| Thrombosis |
4.1% |
| Weight Increased |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Abdominal Pain |
3.3% |
| Acute Generalised Exanthematous Pustulosis |
3.3% |
| Aplastic Anaemia |
3.3% |
|
| Interacting |
| Depression |
23.5% |
| Diabetes Mellitus |
23.5% |
| Drug Use For Unknown Indication |
17.6% |
| Tachyarrhythmia |
11.8% |
| Blood Cholesterol Increased |
5.9% |
| Dyslipidaemia |
5.9% |
| High Density Lipoprotein Decreased |
5.9% |
| Rheumatoid Arthritis |
5.9% |
|
| Myocardial Infarction |
50.0% |
| Pollakiuria |
50.0% |
|
